Beaty O, Sloop C H, Schmid H E, Buckalew V M
Am J Physiol. 1976 Oct;231(4):1300-7. doi: 10.1152/ajplegacy.1976.231.4.1300.
Hemorrhage and hemorrhagic hypotension have been shown to be potent stimulators of renin release. However, the relationship between angiotensinogen consumption and angiotensinogen production has yet to be completely defined during this type of circulatory stress. Peripheral renin activity increased progressively as the blood pressure was decreased stepwise by hemorrhage to 50 mmHg and remained elevated throughout the shock phase of the experiment. Angiotensinogen did not change from control (809 ng/ml) throughout hemorrhabic hypotension and shock. During hemorrhagic hypotension, with the infusion of the angiotensin antagonist, [1-sarcosine, 8-alanine]angiotensin II, angiotensinogen concentration fell progressively from 693 to 208 ng/ml at 50 mmHg. Intravenous angiotensin II infused continuously after the mean blood pressure reached 50 mmHg significantly elevated plasma angiotensinogen concentration. In conclusion, during hemorrhagic hypotension and shock, the kidney and the liver appeared capable of maintaining elevated plasma renin activity and adequate plasma renin substrate, angiotensinogen, respectively. The mechanism responsible for the maintenance of plasma angiotensinogen is suggested to involve a positive-feedback effect of angiotensin II on the liver.
出血和出血性低血压已被证明是肾素释放的强效刺激因素。然而,在这种循环应激类型中,血管紧张素原消耗与血管紧张素原生成之间的关系尚未完全明确。随着通过出血使血压逐步降至50 mmHg,外周肾素活性逐渐增加,并在实验的休克阶段一直保持升高。在整个出血性低血压和休克过程中,血管紧张素原与对照值(809 ng/ml)相比没有变化。在出血性低血压期间,输注血管紧张素拮抗剂[1-肌氨酸,8-丙氨酸]血管紧张素II后,在血压为50 mmHg时,血管紧张素原浓度从693 ng/ml逐渐降至208 ng/ml。平均血压达到50 mmHg后持续静脉输注血管紧张素II可显著提高血浆血管紧张素原浓度。总之,在出血性低血压和休克期间,肾脏和肝脏似乎分别能够维持血浆肾素活性升高和充足的血浆肾素底物即血管紧张素原。推测维持血浆血管紧张素原的机制涉及血管紧张素II对肝脏的正反馈作用。